These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 808091)

  • 21. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin III levels in term and preterm infants measured by rate nephelometry.
    Karmazsin L; Balla G; Misz M; Beck P; Nagy P; Rák K
    Acta Paediatr Hung; 1984; 25(1-2):119-26. PubMed ID: 6477763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new method to quantify β-antithrombin glycoform in plasma reveals increased levels during the acute stroke event.
    de la Morena-Barrio ME; García A; Martínez-Martínez I; Miñano A; Padilla J; Navarro-Fernández J; Roldán V; Águila S; Iniesta JA; Corral J; Vicente V
    Thromb Res; 2015 Sep; 136(3):634-41. PubMed ID: 26186963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of new methods for studies in the area of blood coagulation. 3. Gel diffusion test for quantitative determination of total antithrombin capacity of plasma].
    Doleschel W
    Wien Med Wochenschr; 1972 Oct; 122(42):601-6. PubMed ID: 4628200
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo age dependency of unfractionated heparin in infants and children.
    Newall F; Ignjatovic V; Summerhayes R; Gan A; Butt W; Johnston L; Monagle P
    Thromb Res; 2009 Mar; 123(5):710-4. PubMed ID: 18829072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombin Concentrate Use in Pediatric Extracorporeal Membrane Oxygenation: A Multicenter Cohort Study.
    Wong TE; Nguyen T; Shah SS; Brogan TV; Witmer CM
    Pediatr Crit Care Med; 2016 Dec; 17(12):1170-1178. PubMed ID: 27662567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin-antithrombin III complexes and antithrombin III in amniotic fluid.
    Uszyński M; Kielkowski A; Uszyński W; Zekanowska E
    Gynecol Obstet Invest; 1997; 43(1):29-33. PubMed ID: 9015695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of three methods for the estimation of plasma antithrombin.
    McLellan DS; Devlin JD; Heyse-Moore GH; Aronstam A
    J Clin Pathol; 1980 May; 33(5):438-44. PubMed ID: 6772690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants.
    Bruschettini M; Romantsik O; Zappettini S; Banzi R; Ramenghi LA; Calevo MG
    Cochrane Database Syst Rev; 2016 Mar; 3():CD011636. PubMed ID: 26998583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.
    Persson L; Harila-Saari A; Hed Myrberg I; Heyman M; Nilsson A; Ranta S
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28440015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma.
    de Vonne TL; Mouray H
    Clin Chim Acta; 1978 Nov; 90(1):83-5. PubMed ID: 82495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated aortopulmonary shunt thrombosis in a neonatal patient with a low antithrombin level.
    Niebler RA; Mitchell ME; Scott JP
    World J Pediatr Congenit Heart Surg; 2014 Jan; 5(1):94-6. PubMed ID: 24403363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False assignment of familial antithrombin III deficiency with the von Kaulla assay.
    Cosgriff TM; Hershgold EJ; Martin BA; Carlson KS
    Am J Clin Pathol; 1983 Nov; 80(5):697-9. PubMed ID: 6416053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
    Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
    Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin/antithrombin III complex formation in the neonatal respiratory distress syndrome.
    Schmidt B; Vegh P; Weitz J; Johnston M; Caco C; Roberts R
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):767-70. PubMed ID: 1554199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin sensitivity and resistance in the neonate: an explanation.
    Vieira A; Berry L; Ofosu F; Andrew M
    Thromb Res; 1991 Jul; 63(1):85-98. PubMed ID: 1658964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
    Asai K; Asai M
    Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical multicenter evaluation of a new FXa-based Antithrombin assay.
    Merz M; Böhm-Weigert M; Braun S; Cooper PC; Fischer R; Hickey K; Steffan A; Kemkes-Matthes B; Kitchen S
    Int J Lab Hematol; 2011 Oct; 33(5):498-506. PubMed ID: 21535419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.